EHWM
EXPD icon

Eads & Heald Wealth Management’s Expeditors International EXPD Stock Holding History

Eads & Heald Wealth Management’s Portfolio EXPD Stock Details EXPD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.52M Sell
17,597
-345
-2% -$52.4K 1.26% 23
2025
Q4 		$2.67M Sell
17,942
-311
-2% -$42.3K 1.29% 21
2025
Q3 		$2.24M Sell
18,253
-92
-0.5% -$10.9K 1.07% 28
2025
Q2 		$2.1M Sell
18,345
-329
-2% -$36.8K 1.04% 36
2025
Q1 		$2.25M Sell
18,674
-365
-2% -$42K 1.14% 27
2024
Q4 		$2.11M Buy
19,039
+320
+2% +$38.2K 1.04% 34
2024
Q3 		$2.46M Sell
18,719
-1,042
-5% -$128K 1.17% 27
2024
Q2 		$2.47M Sell
19,761
-432
-2% -$51.5K 1.19% 25
2024
Q1 		$2.46M Sell
20,193
-1,399
-6% -$173K 1.14% 27
2023
Q4 		$2.75M Sell
21,592
-255
-1% -$30.1K 1.32% 17
2023
Q3 		$2.5M Sell
21,847
-102
-0.5% -$12.1K 1.31% 21
2023
Q2 		$2.66M Sell
21,949
-1,168
-5% -$133K 1.31% 19
2023
Q1 		$2.55M Sell
23,117
-522
-2% -$56.7K 1.26% 24
2022
Q4 		$2.46M Sell
23,639
-100
-0.4% -$10.3K 1.25% 26
2022
Q3 		$2.1M Buy
23,739
+387
+2% +$38.7K 1.19% 28
2022
Q2 		$2.28M Sell
23,352
-11
-0% -$1.13K 1.23% 21
2022
Q1 		$2.41M Buy
23,363
+191
+0.8% +$21.1K 1.12% 32
2021
Q4 		$3.11M Sell
23,172
-103
-0.4% -$12.9K 1.35% 12
2021
Q3 		$2.77M Sell
23,275
-141
-0.6% -$17.6K 1.34% 12
2021
Q2 		$2.96M Sell
23,416
-1,785
-7% -$211K 1.45% 8
2021
Q1 		$2.71M Buy
25,201
+34
+0.1% +$3.27K 1.39% 12
2020
Q4 		$2.39M Buy
25,167
+497
+2% +$45.3K 1.29% 22
2020
Q3 		$2.23M Sell
24,670
-2,188
-8% -$186K 1.34% 19
2020
Q2 		$2.04M Sell
26,858
-594
-2% -$43.4K 1.24% 25
2020
Q1 		$1.83M Sell
27,452
-495
-2% -$35.3K 1.29% 25
2019
Q4 		$2.18M Sell
27,947
-48
-0.2% -$3.6K 1.15% 32
2019
Q3 		$2.08M Buy
27,995
+3,182
+13% +$233K 1.16% 33
2019
Q2 		$1.88M Buy
24,813
+21
+0.1% +$1.58K 1.06% 40
2019
Q1 		$1.88M Buy
24,792
+15,133
+157% +$1.09M 1.09% 44
2018
Q4 		$658K Buy
+9,659
New +$678K 0.44% 91

Other funds holding EXPD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Eads & Heald Wealth Management's EXPD Position: Q1 2026 in Review

Eads & Heald Wealth Management reduced its Expeditors International (EXPD) stake by 1.9% in Q1 2026, selling an estimated $52.4K and leaving 17,597 shares worth $2.52M. The position accounts for 1.26% of the portfolio, ranked #23.

Eads & Heald Wealth Management first reported a position in EXPD in Q4 2018 and has held it in 30 quarters since. The position peaked at $3.11M in Q4 2021. 906 funds tracked by Wall St. Rank hold EXPD as of Q1 2026.

  • Eads & Heald Wealth Management held 17,597 shares of Expeditors International worth $2.52M as of Q1 2026.
  • Eads & Heald Wealth Management sold 345 Expeditors International shares in Q1 2026, an estimated $52.4K.
  • Expeditors International made up 1.26% of Eads & Heald Wealth Management's portfolio in Q1 2026, its #23 holding.
  • Eads & Heald Wealth Management first reported a position in Expeditors International in Q4 2018 and has held it in 30 quarters since.
  • Eads & Heald Wealth Management's Expeditors International position peaked at $3.11M in Q4 2021.
  • 906 funds tracked by Wall St. Rank held Expeditors International as of Q1 2026.

Based on Eads & Heald Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.